Advertisement
Screener

Intellicell Biosciences, Inc. Debt Conversion, Converted Instrument, Amount

Intellicell Biosciences, Inc. Debt Conversion, Converted Instrument, Amount

Intellicell Biosciences, Inc. reported Debt Conversion, Converted Instrument, Amount of $2.54 million for the 9-month period ending 2013-09-30, per its 10-Q filed 2013-11-25.

Discontinued › Cash Flow › Financing Activities

us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2013-11-25

  • Intellicell Biosciences, Inc. debt conversion, converted instrument, amount for the quarter ending 2013-09-30 was $1.39M.
  • Intellicell Biosciences, Inc. debt conversion, converted instrument, amount for the quarter ending 2012-12-31 was $0.00.
  • Intellicell Biosciences, Inc. debt conversion, converted instrument, amount for the quarter ending 2012-09-30 was $0.00.
  • Intellicell Biosciences, Inc. debt conversion, converted instrument, amount for fiscal 2012 was $103.65K.
  • Intellicell Biosciences, Inc. debt conversion, converted instrument, amount for fiscal 2011 was $0.00.
Period endDebt Conversion, Converted Instrument, Amount 3 monthDebt Conversion, Converted Instrument, Amount 6 monthDebt Conversion, Converted Instrument, Amount 9 monthDebt Conversion, Converted Instrument, Amount 12 month
2013-09-30$1.39M
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-25
$2.54M
10-Q · filed 2013-11-25
2013-06-30$1.15M
10-Q/A · filed 2013-10-18
2012-12-31$0.00
derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-09-16
$0.00
derived: sum of 2 quarters · filed 2013-09-16
$103.65K
10-K · filed 2013-09-16
2012-09-30$0.00
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-11-28
$103.65K
10-Q/A · filed 2012-11-28
2012-06-30$103.65K
10-Q/A · filed 2012-09-10
2011-12-31$0.00
10-K · filed 2013-09-16
2011-06-30$0.00
10-Q/A · filed 2012-09-10